Oncology Pilot To Highlight Disagreements Between US FDA And Sponsor For Advisory Committees

15 Nov 2019

• By Kate Rawson

'Point/Counterpoint' program grew out of Assessment Aid initiative in the Oncology Center of Excellence and will be unveiled at an upcoming ODAC meeting.

Large Battle Between Medieval Warriors. Medieval Reenactment. - Image — Hopefully the disagreements between the US FDA and oncology sponsors will be less pointed than this depiction.

Oncology Pilot To Highlight Disagreements Between US FDA And Sponsor For Advisory Committees

More from US FDA Performance Tracker

More from Regulatory Trackers